China Nuokang Bio-Pharmaceutical Inc., a biopharmaceutical company, focuses on the research, development, manufacture, marketing, and sale of hospital-based medical products in China. The company provides a diversified portfolio of products across 2,400 hospitals in China. Its principal products include Baquting, a hemocoagulase product; and Aiduo, a cardiovascular stress imaging agent. The companys product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, and treatment and prevention. The company was founded in 1997 and is based in Shenyang, the Peoples Republic of China. China Nuokang Bio-Pharmaceutical Inc. is a subsidiary of Anglo China Bio-technology Investment Holdings Limited.